Delivery Order SPE2DB24D1205-SPE2DB25FCULR

Award Date 2/28/25
Potential Completion Date 3/3/25
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of WEGOVY 1.7 mg/0.75 ml pens, a prescription medication. The contract has a ceiling value of $117,146.87 and a period of performance through September 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The award has a ceiling value of $2,993.38 and an ultimate completion date of July 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has a ceiling value of $42,743.86 and a completion date of December 17, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product. The Delivery Order has a Firm Fixed Price contract type with a ceiling value of $8,068.86 and a period of performance through June 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5 ML, a specialized pharmaceutical product. The contract has a ceiling value of $5,374.14 and a period of performance through November 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medical product, with a ceiling value of $9,183.15 and a performance period through November 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product, with a ceiling value of $9,822.69 and a period of performance through November 5, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML. The delivery order, valued at $1,583.28, is a firm fixed-price contract with a completion date of September 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $14,924.26 and runs through October 18, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC covers a...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The award has a ceiling value of $2,326.71 and a completion date of January 22, 2025. This contract is not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 IDC...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCULR
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a prescription medication. The contract has a ceiling value of $8,616.20 and a performance period ending on March 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award did not have a set-aside designation, indicating open competition.

Generated 5/30/25, 9:54 AM